• Je něco špatně v tomto záznamu ?

Optimizing recombinant production of L-asparaginase 1 from Saccharomyces cerevisiae using response surface methodology

V. Ebrahimi, A. Hashemi

. 2024 ; 69 (6) : 1205-1219. [pub] 20240406

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24020983

Grantová podpora
IR.SBMU.PHARMACY.REC.1401.037 Shahid Beheshti University of Medical Sciences

L-asparaginase is an essential enzyme used in cancer treatment, but its production faces challenges like low yield, high cost, and immunogenicity. Recombinant production is a promising method to overcome these limitations. In this study, response surface methodology (RSM) was used to optimize the production of L-asparaginase 1 from Saccharomyces cerevisiae in Escherichia coli K-12 BW25113. The Box-Behnken design (BBD) was utilized for the RSM modeling, and a total of 29 experiments were conducted. These experiments aimed to examine the impact of different factors, including the concentration of isopropyl-b-LD-thiogalactopyranoside (IPTG), the cell density prior to induction, the duration of induction, and the temperature, on the expression level of L-asparaginase 1. The results revealed that while the post-induction temperature, cell density at induction time, and post-induction time all had a significant influence on the response, the post-induction time exhibited the greatest effect. The optimized conditions (induction at cell density 0.8 with 0.7 mM IPTG for 4 h at 30 °C) resulted in a significant amount of L-asparaginase with a titer of 93.52 μg/mL, which was consistent with the model-based prediction. The study concluded that RSM optimization effectively increased the production of L-asparaginase 1 in E. coli, which could have the potential for large-scale fermentation. Further research can explore using other host cells, optimizing the fermentation process, and examining the effect of other variables to increase production.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24020983
003      
CZ-PrNML
005      
20241105105527.0
007      
ta
008      
241105s2024 xr f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-024-01163-2 $2 doi
035    __
$a (PubMed)38581537
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Ebrahimi, Vida $u Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, No. 2660, Valiasr-Niayesh Junction, Vali-e-Asr Ave, Tehran 1991953381, Iran
245    10
$a Optimizing recombinant production of L-asparaginase 1 from Saccharomyces cerevisiae using response surface methodology / $c V. Ebrahimi, A. Hashemi
520    9_
$a L-asparaginase is an essential enzyme used in cancer treatment, but its production faces challenges like low yield, high cost, and immunogenicity. Recombinant production is a promising method to overcome these limitations. In this study, response surface methodology (RSM) was used to optimize the production of L-asparaginase 1 from Saccharomyces cerevisiae in Escherichia coli K-12 BW25113. The Box-Behnken design (BBD) was utilized for the RSM modeling, and a total of 29 experiments were conducted. These experiments aimed to examine the impact of different factors, including the concentration of isopropyl-b-LD-thiogalactopyranoside (IPTG), the cell density prior to induction, the duration of induction, and the temperature, on the expression level of L-asparaginase 1. The results revealed that while the post-induction temperature, cell density at induction time, and post-induction time all had a significant influence on the response, the post-induction time exhibited the greatest effect. The optimized conditions (induction at cell density 0.8 with 0.7 mM IPTG for 4 h at 30 °C) resulted in a significant amount of L-asparaginase with a titer of 93.52 μg/mL, which was consistent with the model-based prediction. The study concluded that RSM optimization effectively increased the production of L-asparaginase 1 in E. coli, which could have the potential for large-scale fermentation. Further research can explore using other host cells, optimizing the fermentation process, and examining the effect of other variables to increase production.
650    12
$a asparaginasa $x genetika $x biosyntéza $x metabolismus $7 D001215
650    12
$a Saccharomyces cerevisiae $x genetika $x metabolismus $7 D012441
650    12
$a rekombinantní proteiny $x genetika $x metabolismus $7 D011994
650    _2
$a teplota $7 D013696
650    _2
$a isopropylthiogalaktosid $x farmakologie $7 D007544
650    _2
$a Escherichia coli K12 $x genetika $x enzymologie $7 D048168
650    _2
$a fermentace $7 D005285
650    _2
$a Escherichia coli $x genetika $x metabolismus $7 D004926
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hashemi, Atieh $u Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, No. 2660, Valiasr-Niayesh Junction, Vali-e-Asr Ave, Tehran 1991953381, Iran. atieh.hashemi.soltanieh@gmail.com $1 https://orcid.org/0000000171215306
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 69, č. 6 (2024), s. 1205-1219
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38581537 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241105 $b ABA008
991    __
$a 20241105105523 $b ABA008
999    __
$a ok $b bmc $g 2209300 $s 1232973
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 69 $c 6 $d 1205-1219 $e 20240406 $i 1874-9356 $m Folia microbiologica $n Folia Microbiol (Praha) $x MED00011005
GRA    __
$a IR.SBMU.PHARMACY.REC.1401.037 $p Shahid Beheshti University of Medical Sciences
LZP    __
$a Pubmed-20241105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...